MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
15.95
+3.64 (29.57%)
Jul 29, 2026, 3:13 PM EDT - Market open
MapLight Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains $40 → $25 | Buy | Maintains | $40 → $25 | +56.74% | Jul 28, 2026 |
Malcolm Hoffman BMO Capital No rating | BMO Capital | Buy Maintains $20 | Buy | Maintains | $20 | +25.39% | Jul 28, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Downgrades $34 → $21 | Hold | Downgrades | $34 → $21 | +31.66% | Jul 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $45 → $26 | Buy | Reiterates | $45 → $26 | +63.01% | Jul 28, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $45 → $37 | Buy | Reiterates | $45 → $37 | +131.97% | Jul 27, 2026 |
| Needham | Needham | Buy Maintains $45 | Buy | Maintains | $45 | +182.13% | Jul 27, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $43 → $24 | Buy | Maintains | $43 → $24 | +50.47% | Jul 27, 2026 |
| UBS | UBS | Buy Reiterates $48 → $52 | Buy | Reiterates | $48 → $52 | +226.02% | Jul 21, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.